Twinstrand Biosciences Inc.

Seattle, WA

UEI
HPY9BJWV8X31
CAGE
7R5X5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3131 Elliott Ave #750, Seattle, WA 98121, USA
Employees
51-250
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $49,988

Contract awards

Award Agency Obligated Awarded
Twinstrand duplex sequencing mutagenesis kit 75F40124P00263 Food and Drug Administration $49,988
Twinstrand biosciences, INC.:1295692 [22-009170] 75N96022P00267 National Institute of Environmental Health Sciences (NIH) $24,000
Twinstrand biosciences, INC.:1295692 [22-006856] 75N96022P00171 National Institute of Environmental Health Sciences (NIH) $24,167
Sequencing universal kit 75N96021P00311 National Institute of Environmental Health Sciences (NIH) $24,000
Duplex sequencing human genotoxicity assay for analysis of 12 human organoid lung model samples 75F40121P00376 Food and Drug Administration $18,000

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Development of a genotoxicity assay using duplex sequencing R44ES030642 National Institute of Environmental Health Sciences (NIH) $2,956,167
Development of a universal assay for minimal residual disease in acute myeloid leukemia using duplex sequencing R44CA233381 National Cancer Institute (NIH) $8,723,614
Early detection of ovarian cancer using uterine lavage and duplex sequencing R44CA221426 National Cancer Institute (NIH) $2,258,850

Similar vendors

Vendor Location Primary NAICS
Medgenome Inc. UEI Z5KLLZJLJKM5 Foster City, CA 621511 Medical Laboratories
Ultima Genomics, Inc. UEI DXEVRGJ7MW28 Fremont, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Expression Analysis UEI PAL6MX9M9CJ5 Durham, NC 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Phase Genomics Inc. UEI TQ67ST6YELX5 Seattle, WA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Microbiome Insights Inc. UEI JFW3ZN9LZ2T9 — 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Twinstrand Biosciences Inc. is a for-profit corporate entity located in Seattle, Washington, specializing in advanced DNA sequencing services and genomic research technologies. Registered in SAM.gov since November 2016, the company provides innovative genomic analysis solutions with a focus on precise sequencing methodologies and genotoxicity assessment. Their core business involves developing specialized sequencing kits and providing sophisticated genomic research services to federal scientific agencies.

The company has secured multiple federal contract awards primarily from the Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS), demonstrating expertise in genomic research and sequencing technologies. Their contract awards, ranging from $18,000 to $49,987.65, have focused on specialized products like the Twinstrand Duplex Sequencing Mutagenesis Kit, universal sequencing kits, and human genotoxicity assay services. These contracts are consistently structured as purchase orders without specific set-aside designations. Additionally, Twinstrand Biosciences Inc. has participated in sub-contract work, notably with Battelle Memorial Institute for genome sequencing services, which further illustrates their technical capabilities in advanced genomic research and analysis. The company's federal contract portfolio reveals a consistent engagement with federal scientific research agencies, providing high-precision genomic research tools and services.

Quick answers

Is Twinstrand Biosciences Inc. registered in SAM.gov?

Yes. Twinstrand Biosciences Inc.'s SAM.gov registration is active through January 20, 2027.

How much has Twinstrand Biosciences Inc. received in federal contracts?

Federal contracts obligated $49,988 to Twinstrand Biosciences Inc. in fiscal years 2023 through 2027.

What is Twinstrand Biosciences Inc.'s most recent federal award?

Twinstrand Biosciences Inc.'s most recent federal contract award is Twinstrand duplex sequencing mutagenesis kit (75F40124P00263), from Food and Drug Administration, on June 27, 2024.

On GovTribe

See Twinstrand Biosciences Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login